Cleared Traditional

K133652 - GSP NEONATAL TOTAL GALACTOSE KIT

K133652 is an FDA 510(k) clearance for GSP NEONATAL TOTAL GALACTOSE KIT, manufactured by Wallac Oy, A Subsidiary of Perkinelmer, Inc.. The device is a Class 1 Chemistry device with product code JIA cleared through the Traditional 510(k) pathway after a 152-day FDA review.

K133652 · Wallac Oy, A Subsidiary of Perkinelmer, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
152d
Days
Class 1
Risk

K133652 is an FDA 510(k) clearance for the GSP NEONATAL TOTAL GALACTOSE KIT. Classified as Enzymatic Methods, Galactose (product code JIA), Class I - General Controls.

Submitted by Wallac Oy, A Subsidiary of Perkinelmer, Inc. (Waltham, US). The FDA issued a Cleared decision on April 28, 2014 after a review of 152 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1310 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Wallac Oy, A Subsidiary of Perkinelmer, Inc. devices

FDA 510(k) Submission Details - K133652

510(k) Number K133652 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 27, 2013
Decision Date April 28, 2014
Days to Decision 152 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 88d · This submission: 152d
Pathway characteristics
Predicate-based equivalence.

JIA Device Classification - Class 1, General Controls

Product Code JIA Enzymatic Methods, Galactose
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1310
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JIA Enzymatic Methods, Galactose

All 8
Devices cleared under the same product code (JIA) and FDA review panel - the closest regulatory comparables to K133652.
GSP Neonatal Total Galactose kit
K190335 · Perkinelmer, Inc. · Nov 2019
SPOTCHECK NEONATAL TOTAL GALACTOSE MICROPLATE REAGENT KIT
K121101 · Astoria-Pacific, Inc. · Jun 2013
NEONATAL TOTAL GALACTOSE KIT
K071649 · Wallac OY · Aug 2008
QUANTASE TOTAL GALACTOSE SCREENING ASSAY
K990644 · Quantase , Ltd. · Jun 1999
QUANTASE TOTAL GALACTOSE SCREENING ASSAY 500 TEST KIT
K990654 · Quantase , Ltd. · Jun 1999
ACCUWELL TOTAL GALACTOSE, MODEL 6010-EGAL
K991498 · Neometrics, Inc. · Jun 1999